Aikido Pharma Inc (AIKI)

Sector:
INDUSTRIALS
Industry:
COMMERCIAL SERVICES & SUPPLIES
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Anthony C. Hayes
Employees:
6
ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK, NY 10020
347-321-7646

AIkido Pharma Inc. a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Data derived from most recent annual or quarterly report
Market Cap 47.8 Million Shares Outstanding89.681 Million Avg 30-day Volume 1.659 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.06
Price to Revenue0.0 Debt to Equity0.0 EBITDA-5.786 Million
Price to Book Value0.9779 Operating Margin0.0 Enterprise Value-639.494 Thousand
Current Ratio184.086 EPS Growth0.927 Quick Ratio183.73
1 Yr BETA 1.2612 52-week High/Low 2.55 / 0.51 Profit Margin0.0
Operating Cash Flow Growth-1.5971 Altman Z-Score108.3977 Free Cash Flow to Firm -1.611 Million
View SEC Filings from AIKI instead.

View recent insider trading info

Funds Holding AIKI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AIKI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEDWICK TIM S

  • Director
69,756 2021-07-30 1

VANDERZANDEN ROBERT J

  • Director
68,570 2021-07-30 1

BLATTNER GREGORY JAMES

  • Director
61,766 2021-07-30 1

LEMIRE PAUL

  • Director
50,000 2021-07-30 1

DUDLEY ROBERT FREDERICK

  • Director
50,000 2021-07-30 1

WOOL KYLE MICHAEL

  • Director
25,000 2021-07-30 2

HAYES ANTHONY CEO

  • Officer
  • Director
78,430 2021-05-03 3

WEISBLUM ERIC

  • Director
20,000 2018-02-16 0

GOLDBERG HOWARD E

  • Director
0 2016-05-03 0

BALLABON JEFFREY

  • Director
0 2016-05-03 0

REINER FRANK INTERIM CFO

  • Officer
21,630 2016-03-22 0

BROWN DOUGLAS T

  • Director
0 2015-08-05 0

POLTORAK ALEXANDER I.

0 2014-07-03 0

KESNER HARVEY J

No longer subject to file 2014-05-28 0

KARR EDWARD M

0 2014-04-03 0

COHEN RICHARD CHIEF FINANCIAL OFFICER

0 2014-01-06 0

POLLACK MICHAEL H INTERIM CFO

0 2013-10-11 0

ROCKSTAR CONSORTIUM US LP

176,991 2013-07-24 0

LODDER ROBERT A

  • FORMER PRESIDENT
No longer subject to file 2013-06-30 0

CLAYTON ROBERT CFO AND TREASURER

0 2013-04-04 0

ARISTIDES MELISSARATOS

  • Director
0 2012-08-14 0

PETER THOMAS

  • Director
0 2012-08-14 0

KRUGER CLAIRE L CEO

  • Officer
  • Director
0 2011-11-15 0

LEVIN GILBERT V

  • Director
  • 10% Owner
2,364,107 2010-12-22 0

COX PAUL JR CHAIRMAN OF THE BOARD

  • Officer
  • Director
23,152 2008-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AIKIDO PHARMA INC AIKI 2022-01-17 22:15:04 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 21:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 21:15:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 20:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 20:15:04 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 19:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 19:15:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 18:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 18:15:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 17:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 17:15:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 16:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 16:15:04 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 15:45:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 15:15:03 UTC -0.6836 0.7536 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 14:45:03 UTC -0.9913 1.0613 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 14:15:03 UTC -0.9913 1.0613 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 13:45:03 UTC -0.9913 1.0613 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 13:15:03 UTC -0.9913 1.0613 2400000
AIKIDO PHARMA INC AIKI 2022-01-17 12:45:03 UTC -0.9913 1.0613 2400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments